FRESENIUS MEDICAL CARE-ADR (FMS) Fundamental Analysis & Valuation

NYSE:FMS • US3580291066

Current stock price

22.41 USD
+0.06 (+0.27%)
At close:
22.41 USD
0 (0%)
After Hours:

This FMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FMS Profitability Analysis

1.1 Basic Checks

  • FMS had positive earnings in the past year.
  • FMS had a positive operating cash flow in the past year.
  • FMS had positive earnings in each of the past 5 years.
  • FMS had a positive operating cash flow in each of the past 5 years.
FMS Yearly Net Income VS EBIT VS OCF VS FCFFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • With a decent Return On Assets value of 3.16%, FMS is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • With a decent Return On Equity value of 7.35%, FMS is doing good in the industry, outperforming 63.00% of the companies in the same industry.
  • FMS has a Return On Invested Capital (5.30%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for FMS is below the industry average of 8.63%.
  • The last Return On Invested Capital (5.30%) for FMS is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FMS Yearly ROA, ROE, ROICFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of FMS (4.98%) is better than 77.00% of its industry peers.
  • FMS's Profit Margin has declined in the last couple of years.
  • FMS's Operating Margin of 9.00% is fine compared to the rest of the industry. FMS outperforms 77.00% of its industry peers.
  • FMS's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.62%, FMS is in line with its industry, outperforming 53.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FMS has declined.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FMS Yearly Profit, Operating, Gross MarginsFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. FMS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FMS is creating some value.
  • The number of shares outstanding for FMS has been reduced compared to 1 year ago.
  • The number of shares outstanding for FMS has been reduced compared to 5 years ago.
  • The debt/assets ratio for FMS is higher compared to a year ago.
FMS Yearly Shares OutstandingFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
FMS Yearly Total Debt VS Total AssetsFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.80, we must say that FMS is in the distress zone and has some risk of bankruptcy.
  • FMS has a Altman-Z score of 1.80. This is comparable to the rest of the industry: FMS outperforms 44.00% of its industry peers.
  • The Debt to FCF ratio of FMS is 6.19, which is on the high side as it means it would take FMS, 6.19 years of fcf income to pay off all of its debts.
  • FMS's Debt to FCF ratio of 6.19 is in line compared to the rest of the industry. FMS outperforms 53.00% of its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that FMS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.65, FMS perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.8
ROIC/WACC1.03
WACC5.13%
FMS Yearly LT Debt VS Equity VS FCFFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that FMS should not have too much problems paying its short term obligations.
  • FMS has a Current ratio (1.26) which is in line with its industry peers.
  • A Quick Ratio of 0.92 indicates that FMS may have some problems paying its short term obligations.
  • FMS has a worse Quick ratio (0.92) than 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FMS Yearly Current Assets VS Current LiabilitesFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

5

3. FMS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • The Earnings Per Share has been decreasing by -1.51% on average over the past years.
  • The Revenue has been growing slightly by 1.51% in the past year.
  • FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.91% yearly.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
  • The Revenue is expected to grow by 3.69% on average over the next years.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

7

4. FMS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.86, the valuation of FMS can be described as very reasonable.
  • 96.00% of the companies in the same industry are more expensive than FMS, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.17, FMS is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.48, which indicates a very decent valuation of FMS.
  • Based on the Price/Forward Earnings ratio, FMS is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
  • FMS is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.86
Fwd PE 9.48
FMS Price Earnings VS Forward Price EarningsFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 91.00% of the companies in the same industry are more expensive than FMS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 92.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.23
EV/EBITDA 5.86
FMS Per share dataFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%

6

5. FMS Dividend Analysis

5.1 Amount

  • FMS has a Yearly Dividend Yield of 3.74%.
  • Compared to an average industry Dividend Yield of 0.50, FMS pays a better dividend. On top of this FMS pays more dividend than 98.00% of the companies listed in the same industry.
  • FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.74%

5.2 History

  • The dividend of FMS has a limited annual growth rate of 4.43%.
  • FMS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
FMS Yearly Dividends per shareFMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 43.19% of the earnings are spent on dividend by FMS. This is a bit on the high side, but may be sustainable.
  • FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FMS Yearly Income VS Free CF VS DividendFMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FMS Dividend Payout.FMS Dividend Payout, showing the Payout Ratio.FMS Dividend Payout.PayoutRetained Earnings

FMS Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE-ADR

NYSE:FMS (4/2/2026, 8:25:54 PM)

After market: 22.41 0 (0%)

22.41

+0.06 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.27%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.52B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target27.2 (21.37%)
Short Float %0.49%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 3.74%
Yearly Dividend0.87
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)0%
PT rev (3m)-1.95%
EPS NQ rev (1m)21.8%
EPS NQ rev (3m)33.21%
EPS NY rev (1m)5.06%
EPS NY rev (3m)-0.59%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-3.02%
Valuation
Industry RankSector Rank
PE 8.86
Fwd PE 9.48
P/S 0.55
P/FCF 6.23
P/OCF 4.05
P/B 0.82
P/tB N/A
EV/EBITDA 5.86
EPS(TTM)2.53
EY11.29%
EPS(NY)2.36
Fwd EY10.55%
FCF(TTM)3.6
FCFY16.05%
OCF(TTM)5.53
OCFY24.68%
SpS40.5
BVpS27.46
TBVpS-3.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.54
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.8
F-Score8
WACC5.13%
ROIC/WACC1.03
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year71.81%
EBIT Next 3Y24.11%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE-ADR / FMS Fundamental Analysis FAQ

What is the fundamental rating for FMS stock?

ChartMill assigns a fundamental rating of 5 / 10 to FMS.


Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?

ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE-ADR?

FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for FMS stock?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE-ADR (FMS) is 8.86 and the Price/Book (PB) ratio is 0.82.


Can you provide the financial health for FMS stock?

The financial health rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 3 / 10.